Head and neck squamous cell carcinoma (HNSCC) is the sixth most common non-skin
cancer with a tobacco consumption and infection with high-risk human papillomavirus (HPV) …

Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancers
worldwide. More than half of patients with HNSCC eventually experience disease …

Head and neck squamous cell carcinoma (HNSCC) have a high incidence and mortality
rate, and investigating the pathogenesis and potential therapeutic strategies of HNSCC is …

Background One of the increasingly accepted methods to evaluate the privacy of synthetic
data is by measuring the risk of membership disclosure. This is a measure of the F1 …

Oral squamous cell carcinoma is the most common malignant epithelial neoplasm affecting
the oral cavity. While surgical resection is the cornerstone of a multimodal curative …

Background The addition of cetuximab significantly increased the antitumor effect of
programmed cell death protein 1 (PD-1) inhibitors in recurrent or metastatic head and neck …

The monoclonal antibody cetuximab recognizes domain III of the epithelial growth factor
receptor (EGFR) with high-affinity and is an important element in the treatment of several …

The epidermal growth factor receptor (EGFR) is a key player in the normal tissue physiology
and the pathology of cancer. Therapeutic approaches have now been developed to target …

For twelve years, the oncology field has been revolutionized by antibodies targeting immune
checkpoints. They must be considered as a heterogenous family of immunostimulatory …

Head and neck squamous cell carcinomas are rising in incidence worldwide, and despite
the advent of improved surgical and radiation techniques, a substantial proportion of …